International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
South Australian Health and Medical Research Institute South Australian Health and Medical Research Institute The South Australian Health and Medical Research Institute (SAHMRI) is an independent health and medical research institute in Adelaide, South Australia. The institute is housed in an iconic, purpose-built eponymous building in South Australia's health and biomedical precinct on North Terrace, Adelaide. According to SAHMRI itself, the institute is composed of approximately 600 researchers, both local and international. The institute was officially incorporated in December 2009, and opened in its current location on 29 November 2013. As at 2015, the institute receives approximately A$5 million per year in funding from the Government of